{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:26:39Z","timestamp":1790126799486,"version":"4.0.1"},"publisher-location":"Berlin, Heidelberg","reference-count":132,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/82_2025_286","type":"book-chapter","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T08:05:47Z","timestamp":1754640347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Infectious Mononucleosis"],"prefix":"10.1007","author":[{"suffix":"Jr.","given":"Henry H.","family":"Balfour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline R.","family":"Meirhaeghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"286_CR1","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.4049\/jimmunol.1301629","volume":"191","author":"RJ Abbott","year":"2013","unstructured":"Abbott RJ, Quinn LL, Leese AM, Scholes HM, Pachnio A, Rickinson AB (2013) CD8+ T cell responses to lytic EBV infection: late antigen specificities as subdominant components of the total response. J Immunol 191:5398\u20135409. https:\/\/doi.org\/10.4049\/jimmunol.1301629","journal-title":"J Immunol"},{"key":"286_CR2","doi-asserted-by":"publisher","first-page":"e00382","DOI":"10.1128\/JVI","volume":"91","author":"RJ Abbott","year":"2017","unstructured":"Abbott RJ, Pachnio A, Pedroza-Pacheco I, Leese AM, Begum J, Long HM, Croom-Carter D, Stacey A, Moss PAH, Hislop AD, Borrow P, Rickinson AB, Bell AI (2017) Asymptomatic primary infection with Epstein-Barr virus: observations on young adult cases. J Virol 91:e00382-e417. https:\/\/doi.org\/10.1128\/JVI","journal-title":"J Virol"},{"key":"286_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000583","volume":"2","author":"D Adhikary","year":"2007","unstructured":"Adhikary D, Behrends U, Boerschmann H, Pfunder A, Burdach S, Moosmann A, Witter K, Bornkamm GW, Mautner J (2007) Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy. PLoS ONE 2:e583. https:\/\/doi.org\/10.1371\/journal.pone.0000583","journal-title":"PLoS ONE"},{"key":"286_CR4","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1001\/jama.291.15.1875","volume":"291","author":"S Alotaibi","year":"2004","unstructured":"Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B (2004) Epstein-Barr virus in pediatric multiple sclerosis. JAMA 291:1875\u20131879. https:\/\/doi.org\/10.1001\/jama.291.15.1875","journal-title":"JAMA"},{"key":"286_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11481-010-9201-3","volume":"5","author":"A Ascherio","year":"2010","unstructured":"Ascherio A, Munger KL (2010) Epstein-barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol 5:271\u2013277. https:\/\/doi.org\/10.1007\/s11481-010-9201-3","journal-title":"J Neuroimmune Pharmacol"},{"key":"286_CR6","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1182\/blood-2014-01-553024","volume":"124","author":"T Azzi","year":"2014","unstructured":"Azzi T, Lunemann A, Murer A, Ueda S, Beziat V, Malmberg KJ, Staubli G, Gysin C, Berger C, Munz C, Chijioke O, Nadal D (2014) Role for early-differentiated natural killer cells in infectious mononucleosis. Blood 124:2533\u20132543. https:\/\/doi.org\/10.1182\/blood-2014-01-553024","journal-title":"Blood"},{"key":"286_CR7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/000992287201100711","volume":"11","author":"HH Balfour Jr","year":"1972","unstructured":"Balfour HH Jr, Forte FA, Simpson RB, Zolov DM (1972) Penicillin-related exanthems in infectious mononucleosis identical to those associated with ampicillin. Clin Pediatr 11:417\u2013421","journal-title":"Clin Pediatr"},{"key":"286_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jcv.2007.02.002","volume":"39","author":"HH Balfour Jr","year":"2007","unstructured":"Balfour HH Jr, Hokanson KM, Schacherer RM, Fietzer CM, Schmeling DO, Holman CJ, Vezina HE, Brundage RC (2007) A virologic pilot study of valacyclovir for infectious mononucleosis. J Clin Virol 39:16\u201321. https:\/\/doi.org\/10.1016\/j.jcv.2007.02.002","journal-title":"J Clin Virol"},{"key":"286_CR9","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/infdis\/jit321","volume":"208","author":"HH Balfour Jr","year":"2013","unstructured":"Balfour HH Jr, Sifakis F, Sliman JA, Knight JA, Schmeling DO, Thomas W (2013b) Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6\u201319 years in the United States and factors affecting its acquisition. J Infect Dis 208:1286\u20131293. https:\/\/doi.org\/10.1093\/infdis\/jit321","journal-title":"J Infect Dis"},{"key":"286_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41390-019-0591-5","volume":"87","author":"HH Balfour Jr","year":"2020","unstructured":"Balfour HH Jr, Schmeling DO, Grimm-Geris JM (2020) The promise of a prophylactic Epstein-Barr virus vaccine. Pediatr Res 87:345\u2013352. https:\/\/doi.org\/10.1038\/s41390-019-0591-5","journal-title":"Pediatr Res"},{"key":"286_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10091399","author":"HH Balfour Jr","year":"2022","unstructured":"Balfour HH Jr, Meirhaeghe MR, Stancari AL, Geris JM, Condon LM, Cederberg LE (2022) Declining Epstein-Barr virus antibody prevalence in college freshmen strengthens the rationale for a prophylactic EBV vaccine. Vaccines (Basel). https:\/\/doi.org\/10.3390\/vaccines10091399","journal-title":"Vaccines (Basel)"},{"key":"286_CR12","doi-asserted-by":"publisher","unstructured":"Balfour HH Jr, Odumade OA, Schmeling DO, Mullan BD, Ed JA, Knight JA, Vezina HE, Thomas W, Hogquist KA (2013a) Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis 207:80\u201388. https:\/\/doi.org\/10.1093\/infdis\/jis646","DOI":"10.1093\/infdis\/jis646"},{"key":"286_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S1474-4422(07)70196-5","volume":"6","author":"B Banwell","year":"2007","unstructured":"Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, Ness J, Belman A, Boiko A, Bykova O, Waubant E, Mah JK, Stoian C, Kremenchutzky M, Bardini MR, Ruggieri M, Rensel M, Hahn J, Weinstock-Guttman B, Yeh EA, Farrell K, Freedman M, Iivanainen M, Sevon M, Bhan V, Dilenge ME, Stephens D, Bar-Or A (2007) Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol 6:773\u2013781. https:\/\/doi.org\/10.1016\/S1474-4422(07)70196-5","journal-title":"Lancet Neurol"},{"key":"286_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nature05762","volume":"447","author":"ES Barton","year":"2007","unstructured":"Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, Miller VL, Virgin HW (2007) Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447:326\u2013329. https:\/\/doi.org\/10.1038\/nature05762","journal-title":"Nature"},{"key":"286_CR15","first-page":"223","volume":"47","author":"G Bauer","year":"2001","unstructured":"Bauer G (2001) Simplicity through complexity: immunoblot with recombinant antigens as the new gold standard in Epstein-Barr virus serology. Clin Lab 47:223\u2013230","journal-title":"Clin Lab"},{"key":"286_CR16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/pbc.22037","volume":"53","author":"K Beutel","year":"2009","unstructured":"Beutel K, Gross-Wieltsch U, Wiesel T, Stadt UZ, Janka G, Wagner HJ (2009) Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin. Pediatr Blood Cancer 53:184\u2013190. https:\/\/doi.org\/10.1002\/pbc.22037","journal-title":"Pediatr Blood Cancer"},{"key":"286_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj822","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A (2022) Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375:296\u2013301. https:\/\/doi.org\/10.1126\/science.abj822","journal-title":"Science"},{"key":"286_CR18","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.4049\/jimmunol.165.12.7078","volume":"165","author":"N Blake","year":"2000","unstructured":"Blake N, Haigh T, Shaka\u2019a G, Croom-Carter D, Rickinson A (2000) The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1. J Immunol 165:7078\u20137087","journal-title":"J Immunol"},{"key":"286_CR19","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nm0602-594","volume":"8","author":"CM Borza","year":"2002","unstructured":"Borza CM, Hutt-Fletcher LM (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8:594\u2013599. https:\/\/doi.org\/10.1038\/nm0602-594","journal-title":"Nat Med"},{"key":"286_CR20","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1136\/jcp.2007.047977","volume":"60","author":"G Brady","year":"2007","unstructured":"Brady G, MacArthur GJ, Farrell PJ (2007) Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol 60:1397\u20131402. https:\/\/doi.org\/10.1136\/jcp.2007.047977","journal-title":"J Clin Pathol"},{"key":"286_CR21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1084\/jem.171.1.345","volume":"171","author":"SR Burrows","year":"1990","unstructured":"Burrows SR, Sculley TB, Misko IS, Schmidt C, Moss DJ (1990) An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3). J Exp Med 171:345\u2013349","journal-title":"J Exp Med"},{"key":"286_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-immunol-030409-101302","volume":"29","author":"JL Cannons","year":"2011","unstructured":"Cannons JL, Tangye SG, Schwartzberg PL (2011) SLAM family receptors and SAP adaptors in immunity. Annu Rev Immunol 29:665\u2013705. https:\/\/doi.org\/10.1146\/annurev-immunol-030409-101302","journal-title":"Annu Rev Immunol"},{"key":"286_CR23","doi-asserted-by":"publisher","unstructured":"Cederberg LE, Rabinovitch MD, Grimm-Geris JM, Schmeling DO, Filtz EA, Condon LM (2019) Epstein-Barr virus DNA in parental oral secretions: a potential source of infection for their young children. Clin Infect Dis 68: 306\u2013312. https:\/\/doi.org\/10.1093\/cid\/ciy464","DOI":"10.1093\/cid\/ciy464"},{"key":"286_CR24","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.celrep.2013.11.041","volume":"5","author":"O Chijioke","year":"2013","unstructured":"Chijioke O, Muller A, Feederle R, Barros MH, Krieg C, Emmel V, Marcenaro E, Leung CS, Antsiferova O, Landtwing V, Bossart W, Moretta A, Hassan R, Boyman O, Niedobitek G, Delecluse HJ, Capaul R, Munz C (2013) Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection. Cell Rep 5:1489\u20131498. https:\/\/doi.org\/10.1016\/j.celrep.2013.11.041","journal-title":"Cell Rep"},{"key":"286_CR25","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1172\/JCI25078","volume":"115","author":"SC Clute","year":"2005","unstructured":"Clute SC, Watkin LB, Cornberg M, Naumov YN, Sullivan JL, Luzuriaga K, Welsh RM, Selin LK (2005) Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. J Clin Invest 115:3602\u20133612. https:\/\/doi.org\/10.1172\/JCI25078","journal-title":"J Clin Invest"},{"key":"286_CR26","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","volume":"117","author":"JI Cohen","year":"2011","unstructured":"Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE (2011b) Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood 117:5835\u20135849. https:\/\/doi.org\/10.1182\/blood-2010-11-316745","journal-title":"Blood"},{"key":"286_CR27","doi-asserted-by":"publisher","unstructured":"Cohen JI, Fauci AS, Varmus H, Nabel GJ (2011a) Epstein-Barr virus: an important vaccine target for cancer prevention. Sci Transl Med 3:107fs107. https:\/\/doi.org\/10.1126\/scitranslmed.3002878","DOI":"10.1126\/scitranslmed.3002878"},{"key":"286_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu342","author":"LM Condon","year":"2014","unstructured":"Condon LM, Cederberg LE, Rabinovitch MD, Liebo RV, Go JC, Delaney AS, Schmeling DO, Thomas W, Balfour HH Jr (2014) Age-Specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race\/ethnicity and family environment. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciu342","journal-title":"Clin Infect Dis"},{"key":"286_CR29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0887-8994(94)90021-3","volume":"10","author":"KP Connelly","year":"1994","unstructured":"Connelly KP, DeWitt LD (1994) Neurologic complications of infectious mononucleosis. Pediatr Neurol 10:181\u2013184","journal-title":"Pediatr Neurol"},{"key":"286_CR30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1086\/505400","volume":"43","author":"DH Crawford","year":"2006","unstructured":"Crawford DH, Macsween KF, Higgins CD, Thomas R, McAulay K, Williams H, Harrison N, Reid S, Conacher M, Douglas J, Swerdlow AJ (2006) A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin Infect Dis 43:276\u2013282. https:\/\/doi.org\/10.1086\/505400","journal-title":"Clin Infect Dis"},{"key":"286_CR31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jech.52.2.101","volume":"52","author":"NS Crowcroft","year":"1998","unstructured":"Crowcroft NS, Vyse A, Brown DW, Strachan DP (1998) Epidemiology of Epstein-Barr virus infection in pre-adolescent children: application of a new salivary method in Edinburgh, Scotland. J Epidemiol Community Health 52:101\u2013104","journal-title":"J Epidemiol Community Health"},{"key":"286_CR32","unstructured":"de-The G, Day NE, Geser A, Lavoue MF, Ho JH, Simons MJ, Sohier R, Tukei P, Vonka V, Zavadova H (1975) Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study\u2014a review. IARC Sci Publ 3\u201316"},{"key":"286_CR33","doi-asserted-by":"crossref","unstructured":"de-The G, Geser A, Day NE, Tukei PM, Williams EH, Beri DP, Smith PG, Dean AG, Bronkamm GW, Feorino P, Henle W (1978) Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt\u2019s lymphoma from Ugandan prospective study. Nature 274:756\u2013761","DOI":"10.1038\/274756a0"},{"key":"286_CR34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archinte.1923.00110190085006","volume":"32","author":"H Downey","year":"1923","unstructured":"Downey H, McKinlay CA (1923) Acute lymphadenosis compared with acute lymphatic leukemia. Arch Intern Med 32:82\u2013112","journal-title":"Arch Intern Med"},{"key":"286_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085422","volume":"9","author":"SK Dunmire","year":"2014","unstructured":"Dunmire SK, Odumade OA, Porter JL, Reyes-Genere J, Schmeling DO, Bilgic H, Fan D, Baechler EC, Balfour HH Jr, Hogquist KA (2014) Primary EBV infection induces an expression profile distinct from other viruses but similar to hemophagocytic syndromes. PLoS ONE 9:e85422. https:\/\/doi.org\/10.1371\/journal.pone.0085422","journal-title":"PLoS ONE"},{"key":"286_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005286","volume":"11","author":"SK Dunmire","year":"2015","unstructured":"Dunmire SK, Grimm JM, Schmeling DO, Balfour HH Jr, Hogquist KA (2015) The incubation period of primary Epstein-Barr virus infection: viral dynamics and immunologic events. PLoS Pathog 11:e1005286. https:\/\/doi.org\/10.1371\/journal.ppat.1005286","journal-title":"PLoS Pathog"},{"key":"286_CR37","doi-asserted-by":"publisher","first-page":"16606","DOI":"10.1073\/pnas.0407522101","volume":"101","author":"G Ferlazzo","year":"2004","unstructured":"Ferlazzo G, Pack M, Thomas D, Paludan C, Schmid D, Strowig T, Bougras G, Muller WA, Moretta L, Munz C (2004) Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A 101:16606\u201316611. https:\/\/doi.org\/10.1073\/pnas.0407522101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"286_CR38","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1590\/S0037-86822004000500008","volume":"37","author":"CM Figueira-Silva","year":"2004","unstructured":"Figueira-Silva CM, Pereira FE (2004) Prevalence of Epstein-Barr virus antibodies in healthy children and adolescents in Vitoria, State of Espirito Santo, Brazil. Rev Soc Bras Med Trop 37:409\u2013412","journal-title":"Rev Soc Bras Med Trop"},{"key":"286_CR39","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1128\/JCM.42.9.4411.2004","volume":"42","author":"BA Fisher","year":"2004","unstructured":"Fisher BA, Bhalara S (2004) False-positive result provided by rapid heterophile antibody test in a case of acute infection with hepatitis E virus. J Clin Microbiol 42:4411. https:\/\/doi.org\/10.1128\/JCM.42.9.4411.2004","journal-title":"J Clin Microbiol"},{"key":"286_CR40","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/mp.53.5.262","volume":"53","author":"KJ Flavell","year":"2000","unstructured":"Flavell KJ, Murray PG (2000) Hodgkin\u2019s disease and the Epstein-Barr virus. Mol Pathol 53:262\u2013269","journal-title":"Mol Pathol"},{"key":"286_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175574","volume":"12","author":"G Fourcade","year":"2017","unstructured":"Fourcade G, Germi R, Guerber F, Lupo J, Baccard M, Seigneurin A, Semenova T, Morand P, Epaulard O (2017) Evolution of EBV seroprevalence and primary infection age in a French hospital and a city laboratory network, 2000\u20132016. PLoS ONE 12:e0175574. https:\/\/doi.org\/10.1371\/journal.pone.0175574","journal-title":"PLoS ONE"},{"key":"286_CR42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(69)91532-3","volume":"1","author":"P Gerber","year":"1969","unstructured":"Gerber P, Walsh JH, Rosenblum EN, Purcell RH (1969) Association of EB-virus infection with the post-perfusion syndrome. Lancet 1:593\u2013595","journal-title":"Lancet"},{"key":"286_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2022.105267","volume":"155","author":"JM Geris","year":"2022","unstructured":"Geris JM, Stancari AL, Meirhaeghe MR, Gautam S, Cayatte C, Schmeling DO, Okour MF, Brundage RC, Hayes GM, Balfour HH Jr (2022) Rapid antibody responses to Epstein-Barr virus correlate with reduced severity of primary infection. J Clin Virol 155:105267. https:\/\/doi.org\/10.1016\/j.jcv.2022.105267","journal-title":"J Clin Virol"},{"key":"286_CR44","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.4049\/jimmunol.1102462","volume":"190","author":"BD Griffin","year":"2013","unstructured":"Griffin BD, Gram AM, Mulder A, Van Leeuwen D, Claas FH, Wang F, Ressing ME, Wiertz E (2013) EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail. J Immunol 190:1672\u20131684. https:\/\/doi.org\/10.4049\/jimmunol.1102462","journal-title":"J Immunol"},{"key":"286_CR45","doi-asserted-by":"publisher","unstructured":"Grimm JM, Schmeling DO, Dunmire SK, Knight JA, Mullan BD, Ed JA, Brundage RC, Hogquist KA, Balfour HH Jr (2016) Prospective studies of infectious mononucleosis in university students. Clin Transl Immunol 5:e94. https:\/\/doi.org\/10.1038\/cti.2016.48","DOI":"10.1038\/cti.2016.48"},{"key":"286_CR46","first-page":"171","volume":"84","author":"SY Gu","year":"1995","unstructured":"Gu SY, Huang TM, Ruan L, Miao YH, Lu H, Chu CM, Motz M, Wolf H (1995) First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen. Dev Biol Stand 84:171\u2013177","journal-title":"Dev Biol Stand"},{"key":"286_CR47","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1128\/CVI.00754-13","volume":"21","author":"A Guerrero-Ramos","year":"2014","unstructured":"Guerrero-Ramos A, Patel M, Kadakia K, Haque T (2014) Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis. Clin Vaccine Immunol 21:817\u2013823. https:\/\/doi.org\/10.1128\/CVI.00754-13","journal-title":"Clin Vaccine Immunol"},{"key":"286_CR48","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1182\/blood-2007-06-093278","volume":"111","author":"V Hadinoto","year":"2008","unstructured":"Hadinoto V, Shapiro M, Greenough TC, Sullivan JL, Luzuriaga K, Thorley-Lawson DA (2008) On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood 111:1420\u20131427. https:\/\/doi.org\/10.1182\/blood-2007-06-093278","journal-title":"Blood"},{"key":"286_CR49","first-page":"4253","volume":"41","author":"DW Hanto","year":"1981","unstructured":"Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS (1981) Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 41:4253\u20134261","journal-title":"Cancer Res"},{"key":"286_CR50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1303211","author":"DW Hendricks","year":"2014","unstructured":"Hendricks DW, Balfour HH Jr, Dunmire SK, Schmeling DO, Hogquist KA, Lanier LL (2014) Cutting Edge: NKG2ChiCD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus. J Immunol. https:\/\/doi.org\/10.4049\/jimmunol.1303211","journal-title":"J Immunol"},{"key":"286_CR51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(82)91666-X","volume":"1","author":"BM Hendry","year":"1982","unstructured":"Hendry BM, Longmore JM (1982) Systemic lupus erythematosus presenting as infectious mononucleosis with a false positive monospot test. Lancet 1:455","journal-title":"Lancet"},{"key":"286_CR52","first-page":"1147","volume":"43","author":"G Henle","year":"1969","unstructured":"Henle G, Henle W, Clifford P, Diehl V, Kafuko GW, Kirya BG, Klein G, Morrow RH, Munube GM, Pike P, Tukei PM, Ziegler JL (1969) Antibodies to Epstein-Barr virus in Burkitt\u2019s lymphoma and control groups. J Natl Cancer Inst 43:1147\u20131157","journal-title":"J Natl Cancer Inst"},{"key":"286_CR53","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1073\/pnas.84.2.570","volume":"84","author":"W Henle","year":"1987","unstructured":"Henle W, Henle G, Andersson J, Ernberg I, Klein G, Horwitz CA, Marklund G, Rymo L, Wellinder C, Straus SE (1987) Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci U S A 84:570\u2013574","journal-title":"Proc Natl Acad Sci U S A"},{"key":"286_CR54","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1128\/JCM.42.8.3381-3387.2004","volume":"42","author":"RD Hess","year":"2004","unstructured":"Hess RD (2004) Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J Clin Microbiol 42:3381\u20133387. https:\/\/doi.org\/10.1128\/JCM.42.8.3381-3387.2004","journal-title":"J Clin Microbiol"},{"key":"286_CR55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/inf.1983.15.issue-4.03","volume":"15","author":"J Hesse","year":"1983","unstructured":"Hesse J, Ibsen KK, Krabbe S, Uldall P (1983) Prevalence of antibodies to Epstein-Barr virus (EBV) in childhood and adolescence in Denmark. Scand J Infect Dis 15:335\u2013338","journal-title":"Scand J Infect Dis"},{"key":"286_CR56","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jmv.1890390311","volume":"39","author":"A Hille","year":"1993","unstructured":"Hille A, Klein K, Baumler S, Grasser FA, Mueller-Lantzsch N (1993) Expression of Epstein-Barr virus nuclear antigen 1,2A and 2B in the baculovirus expression system: serological evaluation of human antibodies to these proteins. J Med Virol 39:233\u2013241","journal-title":"J Med Virol"},{"key":"286_CR57","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","volume":"25","author":"AD Hislop","year":"2007","unstructured":"Hislop AD, Taylor GS, Sauce D, Rickinson AB (2007) Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 25:587\u2013617. https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141553","journal-title":"Annu Rev Immunol"},{"key":"286_CR58","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1182\/blood-2009-09-238832","volume":"116","author":"AD Hislop","year":"2010","unstructured":"Hislop AD, Palendira U, Leese AM, Arkwright PD, Rohrlich PS, Tangye SG, Gaspar HB, Lankester AC, Moretta A, Rickinson AB (2010) Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets. Blood 116:3249\u20133257. https:\/\/doi.org\/10.1182\/blood-2009-09-238832","journal-title":"Blood"},{"key":"286_CR59","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jnci\/92.18.1522","volume":"92","author":"H Hjalgrim","year":"2000","unstructured":"Hjalgrim H, Askling J, Sorensen P, Madsen M, Rosdahl N, Storm HH, Hamilton-Dutoit S, Eriksen LS, Frisch M, Ekbom A, Melbye M (2000) Risk of Hodgkin\u2019s disease and other cancers after infectious mononucleosis. J Natl Cancer Inst 92:1522\u20131528","journal-title":"J Natl Cancer Inst"},{"key":"286_CR60","doi-asserted-by":"crossref","unstructured":"Hjalgrim H, Friborg J, Melbye M (2007) The epidemiology of EBV and its association with malignant disease. In: Arvin A et al (eds) Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge","DOI":"10.1017\/CBO9780511545313.054"},{"key":"286_CR61","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00000441-195503000-00003","volume":"229","author":"RJ Hoagland","year":"1955","unstructured":"Hoagland RJ (1955) The transmission of infectious mononucleosis. Am J Med Sci 229:262\u2013272","journal-title":"Am J Med Sci"},{"key":"286_CR62","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.7326\/0003-4819-46-6-1184","volume":"46","author":"RJ Hoagland","year":"1957","unstructured":"Hoagland RJ, Henson HM (1957) Splenic rupture in infectious mononucleosis. Ann Intern Med 46:1184\u20131191","journal-title":"Ann Intern Med"},{"key":"286_CR63","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1399-0012.2012.01608.x","volume":"26","author":"CJ Holman","year":"2012","unstructured":"Holman CJ, Karger AB, Mullan BD, Brundage RC, Balfour HH Jr (2012) Quantitative Epstein-Barr virus shedding and its correlation with the risk of post-transplant lymphoproliferative disorder. Clin Transplant 26:741\u2013747. https:\/\/doi.org\/10.1111\/j.1399-0012.2012.01608.x","journal-title":"Clin Transplant"},{"key":"286_CR64","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/ajcp\/72.5.807","volume":"72","author":"CA Horwitz","year":"1979","unstructured":"Horwitz CA, Henle W, Henle G, Penn G, Hoffman N, Ward PC (1979) Persistent falsely positive rapid tests for infectious mononucleosis. Report of five cases with four\u2013six-year follow-up data. Am J Clin Pathol 72:807\u2013811","journal-title":"Am J Clin Pathol"},{"key":"286_CR65","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1182\/blood.V57.5.933.933","volume":"57","author":"CA Horwitz","year":"1981","unstructured":"Horwitz CA, Henle W, Henle G, Goldfarb M, Kubic P, Gehrz RC, Balfour HH Jr, Fleisher GR, Krivit W (1981) Clinical and laboratory evaluation of infants and children with Epstein-Barr virus-induced infectious mononucleosis: report of 32 patients (aged 10\u201348 months). Blood 57:933\u2013938","journal-title":"Blood"},{"key":"286_CR66","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1128\/JVI.00445-07","volume":"81","author":"LM Hutt-Fletcher","year":"2007","unstructured":"Hutt-Fletcher LM (2007) Epstein-Barr virus entry. J Virol 81:7825\u20137832. https:\/\/doi.org\/10.1128\/JVI.00445-07","journal-title":"J Virol"},{"key":"286_CR67","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1017\/S0950268811002457","volume":"140","author":"AE Hwang","year":"2012","unstructured":"Hwang AE, Hamilton AS, Cockburn MG, Ambinder R, Zadnick J, Brown EE, Mack TM, Cozen W (2012) Evidence of genetic susceptibility to infectious mononucleosis: a twin study. Epidemiol Infect 140:2089\u20132095. https:\/\/doi.org\/10.1017\/S0950268811002457","journal-title":"Epidemiol Infect"},{"key":"286_CR68","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.3390\/v4123420","volume":"4","author":"H Iizasa","year":"2012","unstructured":"Iizasa H, Nanbo A, Nishikawa J, Jinushi M, Yoshiyama H (2012) Epstein-Barr Virus (EBV)-associated gastric carcinoma. Viruses 4:3420\u20133439","journal-title":"Viruses"},{"key":"286_CR69","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev-med-041610-134208","volume":"63","author":"GE Janka","year":"2012","unstructured":"Janka GE (2012) Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med 63:233\u2013246. https:\/\/doi.org\/10.1146\/annurev-med-041610-134208","journal-title":"Annu Rev Med"},{"key":"286_CR70","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00008480-200006000-00016","volume":"12","author":"HB Jenson","year":"2000","unstructured":"Jenson HB (2000) Acute complications of Epstein-Barr virus infectious mononucleosis. Curr Opin Pediatr 12:263\u2013268","journal-title":"Curr Opin Pediatr"},{"key":"286_CR71","doi-asserted-by":"publisher","unstructured":"Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL (2011) How I treat hemophagocytic lymphohistiocytosis. Blood 118:4041\u20134052. https:\/\/doi.org\/10.1182\/blood-2011-03-278127","DOI":"10.1182\/blood-2011-03-278127"},{"key":"286_CR72","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1172\/JCI116721","volume":"92","author":"H Kawaguchi","year":"1993","unstructured":"Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M, Tsuchida M, Hanada R, Kinoshita A, Sakurai M, Kobayashi N et al (1993) Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 92:1444\u20131450. https:\/\/doi.org\/10.1172\/JCI116721","journal-title":"J Clin Invest"},{"key":"286_CR73","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","volume":"98","author":"H Kimura","year":"2001","unstructured":"Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T (2001) Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 98:280\u2013286","journal-title":"Blood"},{"key":"286_CR74","doi-asserted-by":"publisher","unstructured":"Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, Imai S, Okano M, Morio T, Yokota S, Tsuchiya S, Yachie A, Imashuku S, Kawa K, Wakiguchi H, Japanese Association for Research on Epstein-Barr V, Related D (2003) Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 187:527\u2013533. https:\/\/doi.org\/10.1086\/367988","DOI":"10.1086\/367988"},{"key":"286_CR75","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/adc.56.1.49","volume":"56","author":"S Krabbe","year":"1981","unstructured":"Krabbe S, Hesse J, Uldall P (1981) Primary Epstein-Barr virus infection in early childhood. Arch Dis Child 56:49\u201352","journal-title":"Arch Dis Child"},{"key":"286_CR76","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/oxfordjournals.aje.a112407","volume":"105","author":"DJ Lang","year":"1977","unstructured":"Lang DJ, Garruto RM, Gajdusek DC (1977) Early acquisition of cytomegalovirus and Epstein-Barr virus antibody in several isolated Melanesian populations. Am J Epidemiol 105:480\u2013487","journal-title":"Am J Epidemiol"},{"key":"286_CR77","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz TV, Brewer RC, Ho PP, Moon JS, Jude KM, Fernandez D, Fernandes RA, Gomez AM, Nadj GS, Bartley CM, Schubert RD, Hawes IA, Vazquez SE, Iyer M, Zuchero JB, Teegen B, Dunn JE, Lock CB, Kipp LB, Cotham VC, Ueberheide BM, Aftab BT, Anderson MS, DeRisi JL, Wilson MR, Bashford-Rogers RJM, Platten M, Garcia KC, Steinman L, Robinson WH (2022) Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603:321\u2013327. https:\/\/doi.org\/10.1038\/s41586-022-04432-7","journal-title":"Nature"},{"key":"286_CR78","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/ana.21978","volume":"67","author":"LI Levin","year":"2010","unstructured":"Levin LI, Munger KL, O\u2019Reilly EJ, Falk KI, Ascherio A (2010) Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 67:824\u2013830. https:\/\/doi.org\/10.1002\/ana.21978","journal-title":"Ann Neurol"},{"key":"286_CR79","doi-asserted-by":"crossref","first-page":"12616","DOI":"10.1073\/pnas.94.23.12616","volume":"94","author":"J Levitskaya","year":"1997","unstructured":"Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci MG (1997) Inhibition of ubiquitin\/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci U S A 94:12616\u201312621","journal-title":"Proc Natl Acad Sci U S A"},{"key":"286_CR80","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1084\/jem.20121437","volume":"210","author":"HM Long","year":"2013","unstructured":"Long HM, Chagoury OL, Leese AM, Ryan GB, James E, Morton LT, Abbott RJ, Sabbah S, Kwok W, Rickinson AB (2013) MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response. J Exp Med 210:933\u2013949. https:\/\/doi.org\/10.1084\/jem.20121437","journal-title":"J Exp Med"},{"key":"286_CR81","doi-asserted-by":"publisher","first-page":"14725","DOI":"10.1073\/pnas.1110900108","volume":"108","author":"S Lopez-Verges","year":"2011","unstructured":"Lopez-Verges S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, Houchins JP, Miller S, Kang SM, Norris PJ, Nixon DF, Lanier LL (2011) Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A 108:14725\u201314732. https:\/\/doi.org\/10.1073\/pnas.1110900108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"286_CR82","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.4049\/jimmunol.1301046","volume":"191","author":"A Lunemann","year":"2013","unstructured":"Lunemann A, Vanoaica LD, Azzi T, Nadal D, Munz C (2013) A distinct subpopulation of human NK cells restricts B cell transformation by EBV. J Immunol 191:4989\u20134995. https:\/\/doi.org\/10.4049\/jimmunol.1301046","journal-title":"J Immunol"},{"key":"286_CR83","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","volume":"362","author":"K Luzuriaga","year":"2010","unstructured":"Luzuriaga K, Sullivan JL (2010) Infectious mononucleosis. N Engl J Med 362:1993\u20132000. https:\/\/doi.org\/10.1056\/NEJMcp1001116","journal-title":"N Engl J Med"},{"key":"286_CR84","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000108113","volume":"28","author":"J Massa","year":"2007","unstructured":"Massa J, Munger KL, O\u2019Reilly EJ, Falk KI, Ascherio A (2007) Plasma titers of antibodies against Epstein-Barr virus BZLF1 and risk of multiple sclerosis. Neuroepidemiology 28:214\u2013215. https:\/\/doi.org\/10.1159\/000108113","journal-title":"Neuroepidemiology"},{"key":"286_CR85","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ijc.2910340506","volume":"34","author":"M Melbye","year":"1984","unstructured":"Melbye M, Ebbesen P, Levine PH, Bennike T (1984) Early primary infection and high Epstein-Barr virus antibody titers in Greenland Eskimos at high risk for nasopharyngeal carcinoma. Int J Cancer 34:619\u2013623","journal-title":"Int J Cancer"},{"key":"286_CR86","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.0105-2896.2005.00224.x","volume":"203","author":"G Menasche","year":"2005","unstructured":"Menasche G, Feldmann J, Fischer A, de Saint BG (2005) Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol Rev 203:165\u2013179. https:\/\/doi.org\/10.1111\/j.0105-2896.2005.00224.x","journal-title":"Immunol Rev"},{"key":"286_CR87","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1479-5876-8-121","volume":"8","author":"A Merlo","year":"2010","unstructured":"Merlo A, Turrini R, Trento C, Zanovello P, Dolcetti R, Rosato A (2010) Impact of gamma-chain cytokines on EBV-specific T cell cultures. J Transl Med 8:121. https:\/\/doi.org\/10.1186\/1479-5876-8-121","journal-title":"J Transl Med"},{"key":"286_CR88","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/jinf.2002.1022","volume":"45","author":"MC Morris","year":"2002","unstructured":"Morris MC, Edmunds WJ (2002) The changing epidemiology of infectious mononucleosis? J Infect 45:107\u2013109","journal-title":"J Infect"},{"key":"286_CR89","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jcv.2007.01.006","volume":"38","author":"TW Nystad","year":"2007","unstructured":"Nystad TW, Myrmel H (2007) Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis. J Clin Virol 38:292\u2013297. https:\/\/doi.org\/10.1016\/j.jcv.2007.01.006","journal-title":"J Clin Virol"},{"key":"286_CR90","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1128\/cmr.00044-10","volume":"24","author":"OA Odumade","year":"2011","unstructured":"Odumade OA, Hogquist KA, Balfour HH Jr (2011) Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev 24:193\u2013209. https:\/\/doi.org\/10.1128\/cmr.00044-10","journal-title":"Clin Microbiol Rev"},{"key":"286_CR91","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1084\/jem.20112401","volume":"209","author":"OA Odumade","year":"2012","unstructured":"Odumade OA, Knight JA, Schmeling DO, Masopust D, Balfour HH Jr, Hogquist KA (2012) Primary Epstein-Barr virus infection does not erode preexisting CD8(+) T cell memory in humans. J Exp Med 209:471\u2013478. https:\/\/doi.org\/10.1084\/jem.20112401","journal-title":"J Exp Med"},{"key":"286_CR92","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/1352458512449682","volume":"19","author":"J Pakpoor","year":"2013","unstructured":"Pakpoor J, Disanto G, Gerber JE, Dobson R, Meier UC, Giovannoni G, Ramagopalan SV (2013) The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis. Mult Scler 19:162\u2013166. https:\/\/doi.org\/10.1177\/1352458512449682","journal-title":"Mult Scler"},{"key":"286_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001187","volume":"9","author":"U Palendira","year":"2011","unstructured":"Palendira U, Low C, Chan A, Hislop AD, Ho E, Phan TG, Deenick E, Cook MC, Riminton DS, Choo S, Loh R, Alvaro F, Booth C, Gaspar HB, Moretta A, Khanna R, Rickinson AB, Tangye SG (2011) Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. PLoS Biol 9:e1001187. https:\/\/doi.org\/10.1371\/journal.pbio.1001187","journal-title":"PLoS Biol"},{"key":"286_CR94","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1128\/JVI.01777-06","volume":"81","author":"IY Pappworth","year":"2007","unstructured":"Pappworth IY, Wang EC, Rowe M (2007) The switch from latent to productive infection in Epstein-Barr virus-infected B cells is associated with sensitization to NK cell killing. J Virol 81:474\u2013482. https:\/\/doi.org\/10.1128\/JVI.01777-06","journal-title":"J Virol"},{"key":"286_CR95","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/bjh.12422","volume":"162","author":"N Parvaneh","year":"2013","unstructured":"Parvaneh N, Filipovich AH, Borkhardt A (2013) Primary immune deficiencies predisposed to Epstein-Barr virus-driven haematological diseases. Br J Haematol 162:573\u2013586. https:\/\/doi.org\/10.1111\/bjh.12422","journal-title":"Br J Haematol"},{"key":"286_CR96","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199509143331103","volume":"333","author":"R Pathmanathan","year":"1995","unstructured":"Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693\u2013698. https:\/\/doi.org\/10.1056\/NEJM199509143331103","journal-title":"N Engl J Med"},{"key":"286_CR97","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514521888","author":"MP Pender","year":"2014","unstructured":"Pender MP, Csurhes PA, Smith C, Beagley L, Hooper KD, Raj M, Coulthard A, Burrows SR, Khanna R (2014) Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis. Mult Scler. https:\/\/doi.org\/10.1177\/1352458514521888","journal-title":"Mult Scler"},{"key":"286_CR98","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.1972.03210050057025","volume":"222","author":"GM Phillips","year":"1972","unstructured":"Phillips GM (1972) False-positive monospot test result in rubella. JAMA 222:585","journal-title":"JAMA"},{"key":"286_CR99","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/infdis\/jir872","volume":"205","author":"E Piriou","year":"2012","unstructured":"Piriou E, Asito AS, Sumba PO, Fiore N, Middeldorp JM, Moormann AM, Ploutz-Snyder R, Rochford R (2012) Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma. J Infect Dis 205:906\u2013913. https:\/\/doi.org\/10.1093\/infdis\/jir872","journal-title":"J Infect Dis"},{"key":"286_CR100","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1212\/01.wnl.0000247665.94088.8d","volume":"67","author":"D Pohl","year":"2006","unstructured":"Pohl D, Krone B, Rostasy K, Kahler E, Brunner E, Lehnert M, Wagner HJ, Gartner J, Hanefeld F (2006) High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 67:2063\u20132065. https:\/\/doi.org\/10.1212\/01.wnl.0000247665.94088.8d","journal-title":"Neurology"},{"key":"286_CR101","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/JSM.0b013e31817e34f8","volume":"18","author":"M Putukian","year":"2008","unstructured":"Putukian M, O\u2019Connor FG, Stricker P, McGrew C, Hosey RG, Gordon SM, Kinderknecht J, Kriss V, Landry G (2008) Mononucleosis and athletic participation: an evidence-based subject review. Clin J Sport Med 18:309\u2013315. https:\/\/doi.org\/10.1097\/JSM.0b013e31817e34f8","journal-title":"Clin J Sport Med"},{"key":"286_CR102","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood.V96.2.443","volume":"96","author":"L Quintanilla-Martinez","year":"2000","unstructured":"Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES (2000) Fulminant EBV(+) T-cell lymphoproliferative disorder following acute\/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 96:443\u2013451","journal-title":"Blood"},{"key":"286_CR103","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1044579X0200086X","volume":"12","author":"N Raab-Traub","year":"2002","unstructured":"Raab-Traub N (2002) Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12:431\u2013441","journal-title":"Semin Cancer Biol"},{"key":"286_CR104","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0092-8674(86)90803-2","volume":"47","author":"N Raab-Traub","year":"1986","unstructured":"Raab-Traub N, Flynn K (1986) The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883\u2013889","journal-title":"Cell"},{"key":"286_CR105","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/icb.2010.151","volume":"89","author":"PC Ramer","year":"2011","unstructured":"Ramer PC, Chijioke O, Meixlsperger S, Leung CS, Munz C (2011) Mice with human immune system components as in vivo models for infections with human pathogens. Immunol Cell Biol 89:408\u2013416. https:\/\/doi.org\/10.1038\/icb.2010.151","journal-title":"Immunol Cell Biol"},{"key":"286_CR106","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature05257","volume":"444","author":"S Rigaud","year":"2006","unstructured":"Rigaud S, Fondaneche MC, Lambert N, Pasquier B, Mateo V, Soulas P, Galicier L, Le Deist F, Rieux-Laucat F, Revy P, Fischer A, de Saint BG, Latour S (2006) XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444:110\u2013114. https:\/\/doi.org\/10.1038\/nature05257","journal-title":"Nature"},{"key":"286_CR107","first-page":"207","volume":"1","author":"RG Robinson","year":"1988","unstructured":"Robinson RG (1988) Abdominal complications of infectious mononucleosis. J Am Board Fam Pract 1:207\u2013210","journal-title":"J Am Board Fam Pract"},{"key":"286_CR108","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu204","author":"K Rostgaard","year":"2014","unstructured":"Rostgaard K, Wohlfahrt J, Hjalgrim H (2014) A genetic basis for infectious mononucleosis: evidence from a family study of hospitalized cases in Denmark. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciu204","journal-title":"Clin Infect Dis"},{"key":"286_CR109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003147","volume":"9","author":"R Rubicz","year":"2013","unstructured":"Rubicz R, Yolken R, Drigalenko E, Carless MA, Dyer TD, Bauman L, Melton PE, Kent JW Jr, Harley JB, Curran JE, Johnson MP, Cole SA, Almasy L, Moses EK, Dhurandhar NV, Kraig E, Blangero J, Leach CT, Goring HH (2013) A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1). PLoS Genet 9:e1003147. https:\/\/doi.org\/10.1371\/journal.pgen.1003147","journal-title":"PLoS Genet"},{"key":"286_CR110","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jama.1971.03190210151022","volume":"218","author":"L Sadoff","year":"1971","unstructured":"Sadoff L, Goldsmith O (1971) False-positive infectious mononucleosis spot test in pancreatic carcinoma. JAMA 218:1297\u20131298","journal-title":"JAMA"},{"key":"286_CR111","doi-asserted-by":"crossref","first-page":"636","DOI":"10.7326\/0003-4819-104-5-636","volume":"104","author":"RT Schooley","year":"1986","unstructured":"Schooley RT, Carey RW, Miller G, Henle W, Eastman R, Mark EJ, Kenyon K, Wheeler EO, Rubin RH (1986) Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. Ann Intern Med 104:636\u2013643","journal-title":"Ann Intern Med"},{"key":"286_CR112","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0928-0197(98)00061-0","volume":"11","author":"J Schubert","year":"1998","unstructured":"Schubert J, Zens W, Weissbrich B (1998) Comparative evaluation of the use of immunoblots and of IgG avidity assays as confirmatory tests for the diagnosis of acute EBV infections. J Clin Virol 11:161\u2013172","journal-title":"J Clin Virol"},{"key":"286_CR113","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood.V71.5.1234.1234","volume":"71","author":"RS Shapiro","year":"1988","unstructured":"Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR, Arthur DC, Patton DF, Greenberg JS, Burke B et al (1988) Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234\u20131243","journal-title":"Blood"},{"key":"286_CR114","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1093\/infdis\/jit093","volume":"207","author":"JA Slyker","year":"2013","unstructured":"Slyker JA, Casper C, Tapia K, Richardson B, Bunts L, Huang ML, Maleche-Obimbo E, Nduati R, John-Stewart G (2013) Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women. J Infect Dis 207:1798\u20131806. https:\/\/doi.org\/10.1093\/infdis\/jit093","journal-title":"J Infect Dis"},{"key":"286_CR115","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1086\/523813","volume":"196","author":"EM Sokal","year":"2007","unstructured":"Sokal EM, Hoppenbrouwers K, Vandermeulen C, Moutschen M, Leonard P, Moreels A, Haumont M, Bollen A, Smets F, Denis M (2007) Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults. J Infect Dis 196:1749\u20131753. https:\/\/doi.org\/10.1086\/523813","journal-title":"J Infect Dis"},{"key":"286_CR116","first-page":"410","volume":"31","author":"TP Sprunt","year":"1920","unstructured":"Sprunt TP, Evans FA (1920) Mononuclear leucocytosis in reaction to acute infections (\u201cinfectious mononucleosis\u201d). Johns Hopkins Hosp Bull 31:410\u2013417","journal-title":"Johns Hopkins Hosp Bull"},{"key":"286_CR117","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/1352458513498829","volume":"20","author":"K Strautins","year":"2014","unstructured":"Strautins K, Tschochner M, James I, Choo L, Dunn DS, Pedrini M, Kermode A, Carroll W, Nolan D (2014) Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk. Mult Scler 20:286\u2013294. https:\/\/doi.org\/10.1177\/1352458513498829","journal-title":"Mult Scler"},{"key":"286_CR118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0040027","volume":"4","author":"T Strowig","year":"2008","unstructured":"Strowig T, Brilot F, Arrey F, Bougras G, Thomas D, Muller WA, Munz C (2008) Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma. PLoS Pathog 4:e27. https:\/\/doi.org\/10.1371\/journal.ppat.0040027","journal-title":"PLoS Pathog"},{"key":"286_CR119","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1182\/blood-2010-02-270678","volume":"116","author":"T Strowig","year":"2010","unstructured":"Strowig T, Chijioke O, Carrega P, Arrey F, Meixlsperger S, Ramer PC, Ferlazzo G, Munz C (2010) Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 116:4158\u20134167. https:\/\/doi.org\/10.1182\/blood-2010-02-270678","journal-title":"Blood"},{"key":"286_CR120","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/infdis\/154.5.842","volume":"154","author":"CV Sumaya","year":"1986","unstructured":"Sumaya CV, Ench Y (1986) Epstein-Barr virus infections in families: the role of children with infectious mononucleosis. J Infect Dis 154:842\u2013850","journal-title":"J Infect Dis"},{"key":"286_CR121","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/infdis\/131.4.403","volume":"131","author":"CV Sumaya","year":"1975","unstructured":"Sumaya CV, Henle W, Henle G, Smith MH, LeBlanc D (1975) Seroepidemiologic study of Epstein-Barr virus infections in a rural community. J Infect Dis 131:403\u2013408","journal-title":"J Infect Dis"},{"key":"286_CR122","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0090-1229(84)90029-1","volume":"30","author":"E Svedmyr","year":"1984","unstructured":"Svedmyr E, Ernberg I, Seeley J, Weiland O, Masucci G, Tsukuda K, Szigeti R, Masucci MG, Blomogren H, Berthold W (1984) Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis. Clin Immunol Immunopathol 30:437\u2013450","journal-title":"Clin Immunol Immunopathol"},{"key":"286_CR123","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1440-1827.2006.01936.x","volume":"56","author":"K Takeuchi","year":"2006","unstructured":"Takeuchi K, Tanaka-Taya K, Kazuyama Y, Ito YM, Hashimoto S, Fukayama M, Mori S (2006) Prevalence of Epstein-Barr virus in Japan: trends and future prediction. Pathol Int 56:112\u2013116. https:\/\/doi.org\/10.1111\/j.1440-1827.2006.01936.x","journal-title":"Pathol Int"},{"key":"286_CR124","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/infdis\/174.2.324","volume":"174","author":"E Tynell","year":"1996","unstructured":"Tynell E, Aurelius E, Brandell A, Julander I, Wood M, Yao QY, Rickinson A, Akerlund B, Andersson J (1996) Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis 174:324\u2013331","journal-title":"J Infect Dis"},{"key":"286_CR125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jmv.1890150103","volume":"15","author":"AR Venkitaraman","year":"1985","unstructured":"Venkitaraman AR, Lenoir GM, John TJ (1985) The seroepidemiology of infection due to Epstein-Barr virus in southern India. J Med Virol 15:11\u201316","journal-title":"J Med Virol"},{"key":"286_CR127","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1128\/JVI.72.7.5552-5558.1998","volume":"72","author":"X Wang","year":"1998","unstructured":"Wang X, Kenyon WJ, Li Q, Mullberg J, Hutt-Fletcher LM (1998) Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J Virol 72:5552\u20135558","journal-title":"J Virol"},{"key":"286_CR128","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(81)91527-0","volume":"2","author":"HB Warner","year":"1981","unstructured":"Warner HB, Carp RI (1981) Multiple sclerosis and Epstein-Barr virus. Lancet 2:1290","journal-title":"Lancet"},{"key":"286_CR129","first-page":"19","volume":"84","author":"LR White","year":"1985","unstructured":"White LR, Karofsky PS (1985) Review of the clinical manifestations, laboratory findings, and complications of infectious mononucleosis. Wis Med J 84:19\u201325","journal-title":"Wis Med J"},{"key":"286_CR130","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2141.2005.05452.x","volume":"129","author":"H Williams","year":"2005","unstructured":"Williams H, McAulay K, Macsween KF, Gallacher NJ, Higgins CD, Harrison N, Swerdlow AJ, Crawford DH (2005) The immune response to primary EBV infection: a role for natural killer cells. Br J Haematol 129:266\u2013274. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05452.x","journal-title":"Br J Haematol"},{"key":"286_CR131","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/vim.2008.0086","volume":"22","author":"EJ Yager","year":"2009","unstructured":"Yager EJ, Szaba FM, Kummer LW, Lanzer KG, Burkum CE, Smiley ST, Blackman MA (2009) Gamma-Herpesvirus-induced protection against bacterial infection is transient. Viral Immunol 22:67\u201372. https:\/\/doi.org\/10.1089\/vim.2008.0086","journal-title":"Viral Immunol"},{"key":"286_CR132","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/infdis\/jix263","volume":"216","author":"JE Yager","year":"2017","unstructured":"Yager JE, Magaret AS, Kuntz SR, Selke S, Huang ML, Corey L, Casper C, Wald A (2017) Valganciclovir for the suppression of Epstein-Barr virus replication. J Infect Dis 216:198\u2013202. https:\/\/doi.org\/10.1093\/infdis\/jix263","journal-title":"J Infect Dis"},{"key":"286_CR133","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.immuni.2012.05.017","volume":"36","author":"F Zhao","year":"2012","unstructured":"Zhao F, Cannons JL, Dutta M, Griffiths GM, Schwartzberg PL (2012) Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis. Immunity 36:1003\u20131016. https:\/\/doi.org\/10.1016\/j.immuni.2012.05.017","journal-title":"Immunity"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2025_286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T08:05:53Z","timestamp":1754640353000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2025_286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":132,"URL":"https:\/\/doi.org\/10.1007\/82_2025_286","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"9 August 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}